Sean Brynjelsen
Chief Executive Officer presso ETON PHARMACEUTICALS, INC.
Patrimonio netto: 5 M $ in data 29/02/2024
Profilo
Sean E.
Brynjelsen is President, Chief Executive Officer & Director at Eton Pharmaceuticals, Inc.
He previously was Senior Vice President-Global Business Development at Akorn, Inc. and Executive Vice President-Business Development for Sagent Pharmaceuticals, Inc.
He received an MBA from the University of Notre Dame and a graduate degree and an undergraduate degree from the University of Illinois.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
13/02/2024 | 1 074 940 ( 4.19% ) | 5 M $ | 29/02/2024 |
Posizioni attive di Sean Brynjelsen
Società | Posizione | Inizio |
---|---|---|
ETON PHARMACEUTICALS, INC. | Chief Executive Officer | 01/06/2017 |
Precedenti posizioni note di Sean Brynjelsen
Società | Posizione | Fine |
---|---|---|
SAGENT PHARMACEUTICALS INC | Corporate Officer/Principal | 01/06/2017 |
AKORN, INC. | Chief Tech/Sci/R&D Officer | 07/02/2014 |
Formazione di Sean Brynjelsen
University of Notre Dame | Masters Business Admin |
University of Illinois | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
ETON PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 2 |
---|---|
Akorn, Inc.
Akorn, Inc. Pharmaceuticals: MajorHealth Technology Akorn, Inc. engages in the development, manufacture, and marketing of generic and prescription pharmaceuticals, and animal and consumer health products. It manufactures and markets branded and generic products including ophthalmic, injectable, oral liquids, topical, inhalants, and nasal sprays. The company was founded in 1971 and is headquartered in Lake Forest, IL. | Health Technology |
Sagent Pharmaceuticals, Inc.
Sagent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sagent Pharmaceuticals, Inc. engages in the developing, manufacturing, and marketing of medical products. It offers injectable products such as amikacin sulfate, ampicillin and sulbactam, cefazolin, piperacillin and tazobactam, and vancomycin hydrochloride. The company was founded by Jeffrey M. Yordon in 2006 and is headquartered in Schaumburg, IL. | Health Technology |